Literature DB >> 12531083

Long-term consequences of respiratory syncytial virus (RSV) bronchiolitis.

L Bont1, W M Aalderen, J L Kimpen.   

Abstract

Despite differences in study design, follow-up studies consistently show that approximately half of the infants with respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) go on to have recurrent wheezing episodes during childhood. Respiratory symptoms are associated with abnormal lung function, including bronchial hyper-responsiveness. Wheezing symptoms following RSV LRTI gradually decrease, and it appears that during school age airway morbidity is no longer related to RSV LRTI during infancy. Mechanisms underlying the association between RSV LRTI and long-term airway morbidity are poorly understood. On the one hand, abnormal airway function that is congenitally present or acquired before RSV LRTI occurs could be the cause of both RSV LRTI and subsequent recurrent wheezing. On the other hand, it is possible that RSV LRTI causes changes in the lower airways or the immune system that result in long-term airway morbidity. Animal models suggest that RSV infection can promote the development of allergic sensitization, but most studies in humans do not indicate a role for atopy in the development of recurrent wheezing following RSV LRTI.

Entities:  

Mesh:

Year:  2000        PMID: 12531083     DOI: 10.1053/prrv.2000.0052

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN: 1526-0542            Impact factor:   2.726


  17 in total

1.  Systemic eosinophil response induced by respiratory syncytial virus.

Authors:  C A Lindemans; J L L Kimpen; B Luijk; J Heidema; D Kanters; C K van der Ent; L Koenderman
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

2.  Cost effectiveness of palivizumab for respiratory syncytial virus prophylaxis in high-risk children: a UK analysis.

Authors:  Mark J C Nuijten; Wolfgang Wittenberg; Maximilian Lebmeier
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

3.  Respiratory syncytial virus and seasonal influenza cause similar illnesses in children with sickle cell disease.

Authors:  Sara Christina Sadreameli; Megan E Reller; David G Bundy; James F Casella; John J Strouse
Journal:  Pediatr Blood Cancer       Date:  2014-01-31       Impact factor: 3.167

4.  Predicting outcome in ex-premature infants supported with extracorporeal membrane oxygenation for acute hypoxic respiratory failure.

Authors:  K L Brown; G Walker; D J Grant; K Tanner; D A Ridout; L S Shekerdemian; J H Smith; C Davis; R K Firmin; A P Goldman
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-09       Impact factor: 5.747

5.  Seasonality of long term wheezing following respiratory syncytial virus lower respiratory tract infection.

Authors:  L Bont; M Steijn; W M C Van Aalderen; F Brus; J M Th Draaisma; R A A M Van Diemen-Steenvoorde; M Pekelharing-Berghuis; J L L Kimpen
Journal:  Thorax       Date:  2004-06       Impact factor: 9.139

6.  Clinical and epidemiologic factors related to subsequent wheezing after virus-induced lower respiratory tract infections in hospitalized pediatric patients younger than 3 years.

Authors:  Aya Takeyama; Koichi Hashimoto; Masatoki Sato; Toshiko Sato; Yoichi Tomita; Ryo Maeda; Masaki Ito; Masahiko Katayose; Yukihiko Kawasaki; Mitsuaki Hosoya
Journal:  Eur J Pediatr       Date:  2014-02-18       Impact factor: 3.183

7.  Local interleukin-10 production during respiratory syncytial virus bronchiolitis is associated with post-bronchiolitis wheeze.

Authors:  Annemieke Schuurhof; Riny Janssen; Hanneke de Groot; Hennie M Hodemaekers; Arja de Klerk; Jan Ll Kimpen; Louis Bont
Journal:  Respir Res       Date:  2011-09-12

8.  Combined fluticasone propionate and salmeterol reduces RSV infection more effectively than either of them alone in allergen-sensitized mice.

Authors:  Rajeswari Singam; Prasanna K Jena; Sumita Behera; Gary R Hellermann; Richard F Lockey; Dennis Ledford; Shyam S Mohapatra
Journal:  Virol J       Date:  2006-05-23       Impact factor: 4.099

9.  Cost effectiveness of palivizumab in Spain: an analysis using observational data.

Authors:  Mark J Nuijten; Wolfgang Wittenberg
Journal:  Eur J Health Econ       Date:  2009-12-05

10.  Severe lower respiratory tract infection in early infancy and pneumonia hospitalizations among children, Kenya.

Authors:  Patrick Kiio Munywoki; Eric O Ohuma; Mwanajuma Ngama; Evasius Bauni; J Anthony G Scott; D James Nokes
Journal:  Emerg Infect Dis       Date:  2013-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.